Timeline Family Smoking Prevention and Tobacco Control Act

Home / Resources / FDA Center for Tobacco Products / Timeline Family Smoking Prevention and Tobacco Control Act

Timeline Family Smoking Prevention and Tobacco Control Act

Timeline Family Smoking Prevention and Tobacco Control Act
Download the Family Smoking and Tobacco Control Act (PDF 360 KB)

Disclaimer
This timeline is not a complete summary of the law. It is very important to note that in order to understand the full context of each section described below, you must read the actual section of the Tobacco Control Act. To help you do that, for each section described, we provide the section number of the Act.

*Please note: For an action that has already happened, we show the actual date it was completed. For an action that will happen in the future, we show the upcoming date. Some of the dates shown below are different from the dates contained in the Tobacco Control Act. This is because the dates in these sections were changed in accordance with section 6 of the Tobacco Control Act.

Return to: The Family Smoking and Tobacco Control Act

Content provided and maintained by the US Food and Drug Administration (FDA).

Date Action
June 2009 President Obama signed the Family Smoking Prevention and Tobacco Control Act into law
July 2009 Established collection of user fees from industry
– Sec. 919
August 2009 The Center for Tobacco Products was established
– Sec. 901(e)
September 2009 Tobacco Control Act ban on flavored cigarettes (other than menthol) took effect
– Sec. 907(a)(1)(A)
November 2009 Published final guidance to assist persons making tobacco product ingredient submissions to FDA
– Sec. 904(a)(1)
March 2010 Established 12-member Tobacco Products Scientific Advisory Committee
– Sec. 917
March 2010 Published final rule restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents (reissued 1996 rule)
– Sec. 102(a)
April 2010 Published final guidance to assist persons submitting to FDA all documents developed after 6/22/09 that relate to health, toxicological, behavioral or psychological effects of tobacco products and their constituents, including smoke constituents, ingredients, components, and additives
– Sec. 904(a)(4)
June 2010 Tobacco Control Act requirements regarding warning labels, advertisements, and rotation of warnings for smokeless tobacco products took effect

– Sec. 204(a), 204(b)(3)(A-B)
June 2010 FDA began awarding state enforcement contracts
– Sec. 102(d)(2)(D)(4)
June 2010 Tobacco Control Act ban on tobacco products labeled or advertised with misleading terms “light” “mild” “low” or similar descriptors took effect
– Sec. 911(a-b)
October 2010 Published Enforcement Action Plan for promotion and advertising restrictions, which covers the sale of menthol and other cigarettes to youth (especially in minority communities)
– Sec. 105(a)(1)
November 2010 Published proposed regulation that would require color graphics depicting the negative health consequences of smoking to accompany the 9 new warning statements in the Tobacco Control Act on cigarette packages and in cigarette advertisements
– Sec. 201(d)
March 2011 Report from the Tobacco Products Scientific Advisory Committee on the public health effects of menthol in cigarettes to FDA
– Sec. 907(e)(1-2)
June 2011 Publish final regulation requiring color graphics depicting the negative health consequences of smoking to accompany the 9 new warning statements in the Tobacco Control Act on cigarette packages and in cigarette advertisements
– Sec. 201(d)
July 2011 Publish regulations establishing procedures for requesting an exemption from the requirement to establish substantial equivalence
– Sec. 905(j)(3)
October 2011 Publish regulation regarding the sale and distribution of tobacco products to youth via the Internet, mail order, or other non-face-to-face exchanges
– Sec. 906(d)(4)(A)(i)
March 2012 Report from the Tobacco Products Scientific Advisory Committee on dissolvable tobacco products
– Sec. 907(f)
April 2012 Publish regulations to address the promotion and marketing of tobacco sold or distributed over the Internet, by mail order, or through other non-face-to-face exchanges between a retailer and a consumer
– Sec. 906(d)(4)(A)(ii)
April 2012 Establish a list of harmful and potentially harmful constituents in tobacco products, including smoke constituents, by brand and subbrand. Publish a public notice requesting scientific and other information on the harmful constituents in tobacco products and smoke
– Sec. 904(e)
April 2012 Publish regulations and/or guidance on the scientific evidence required to assess and review modified risk tobacco products
– Sec. 911(l)(1)
April 2012 Publish regulations or guidance permitting the filing of a single application for a new tobacco product (under 910) the applicant seeks to market as a modified risk product
– Sec. 911(l)(4)
April 2013 Publish the list of harmful and potentially harmful constituents in a format that is understandable and not misleading to the lay public

– Sec. 904(a)(3), 904(d)(1), 904(e)

April 2013 Submit a report to Congress on regulating, promoting, and encouraging the development of innovative products and treatments to reduce or eliminate tobacco dependence and harm
– Sec. 918(b)
April 2013 Submit to Congress an implementation report on:

  • Progress and impediments to implementing the Act
  • Number of new products and modified risk product applications received and
  • Number of employees engaged in implementing the Act

– Sec. 106(a)

April 2013 Submit a report to Congress on tobacco exports
–Sec. 103(l)(3)
April 2013 Publish a regulation that requires testing and reporting of tobacco product constituents, ingredients, and additives, including smoke constituents, by brand and sub brand that FDA determines should be tested
– Sec. 915(a-b)
April 2015 Submit a report to Congress on the health implications of raising the minimum age to purchase tobacco products, based on a study conducted by an expert panel
– Sec. 104
April 2015 Submit a report to Congress on research into consumer understanding of harmful ingredients and recommend whether annual publication of the harmful and potential harmful constituent list should be continued or modified
– Sec. 904(d)(2)